Centrality percentage of countries in global drug innovation network: Total new drugs vs. NME drugs (2006–2010).

Note: The percentages in the rows of Difference are equal to values of relative NME minus values of according total new drugs. The differences are used to measure changes of the centrality share of countries from innovation network based on total new drugs to the network constructed by NME. The percentages in the total new drugs and NME refer to the share of national or regional centrality in total sum of relative centrality.